CareCloud to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
Rhea-AI Summary
CareCloud (Nasdaq: CCLD) will release fourth quarter and full year 2025 financial results before market open on March 12, 2026.
A conference call for investors will follow at 8:30 a.m. ET with a live webcast, audio options, downloadable slides, and a replay available at ir.carecloud.com/events.
Positive
- None.
Negative
- None.
Details
News Market Reaction – CCLD
On Feb 19, the day this news came out, CCLD closed 2.46% above the previous close.
Data tracked by StockTitan Argus for the Feb 19 session.
Key Figures
- Quarter end date
- December 31, 2025
- Fourth quarter and full year 2025 reporting period
- Earnings release date
- March 12, 2026
- Scheduled release before market open
- Current share price
- $2.44
- Price prior to earnings date announcement
- Price change
- 1.24%
- 24-hour move before the news
- Conference call time
- 8:30 a.m. ET
- Investor call following earnings release
- Replay access code
- 13758591
- Audio-only replay of earnings call
Historical Context
-
Memorial Hospital chose HealthLine clinical supply chain platform.
-
Wellsoft ranked #1 EHR for Emergency Medicine by Black Book 2026.
-
Declared monthly preferred dividends and additional Series B arrearage payment.
-
Affinity Urgent Care adopted Wellsoft, targeting urgent care market expansion.
-
New CSO and CEO roles to drive enterprise AI and execution.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOMERSET, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2025 before the market opens on Thursday, March 12, 2026. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.
The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing “CareCloud, Inc. Fourth Quarter 2025 Results Conference Call.” Investors who opt for audio-only will need to download the related slides at ir.carecloud.com/events.
A replay of the conference call and related presentation slides will be available approximately three hours after conclusion of the call at the same link. An audio-only option can also be accessed by dialing 412-317-6671 and providing the access code 13758591.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
SOURCE CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.